Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:46 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–408 of 2,510 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: RAPID Clear all

Conditions: Heart Failure
Interventions: Triage® B-Type Natriuretic Peptide (BNP) Test; Device
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 18 Years and older
Enrollment: 720 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 29
States / cities: Scottsdale, Arizona • San Diego, California • San Francisco, California + 25 more

Conditions: Colorectal Cancer
Interventions: Not listed
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 40 Years and older
Enrollment: 850 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 44
States / cities: Phoenix, Arizona • Canoga Park, California • Chula Vista, California + 39 more

Conditions: Advanced Solid Tumors
Interventions: INCB081776, INCMGA00012; Drug
Lead sponsor: Incyte Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 9
States / cities: New Haven, Connecticut • Boston, Massachusetts • Hackensack, New Jersey + 6 more

Conditions: COVID-19
Interventions: ADVANCE Steering Committee interventions; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 37,122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Schwenksville, Pennsylvania

Conditions: Malignant Melanoma, Neoplasms
Interventions: Rifampin, Vemurafenib; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 4
States / cities: Rogers, Arkansas • Pleasant Hill, California • Middletown, Ohio + 1 more

Conditions: Fasting
Interventions: oral carbohydrate challenge; Dietary Supplement
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Diabetes or With New Hyperglycemia
Interventions: Glucommander, Standard insulin infusion algorithm; Device · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 4
States / cities: Atlanta, Georgia • Memphis, Tennessee • Seattle, Washington

Conditions: Hiv
Interventions: TelePrEP; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 14 Years to 24 Years · Male only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Mental Health
Interventions: IMPACT Methods to Identify and Prioritize Determinants (Challenge I), Challenge and Match strategies to Prioritized Determinants (Challenge II); Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Hepatitis C
Interventions: OraQuick HCV Rapid Antibody Test; Diagnostic Test
Lead sponsor: TruCare Internal Medicine & Infectious Disease; Other
Eligibility: 18 Years and older
Enrollment: 3,051 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: DuBois, Pennsylvania

Conditions: Healthy
Interventions: Colchicine, Colchicine/Probenecid; Drug
Lead sponsor: Mutual Pharmaceutical Company, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Obsessive-Compulsive Disorder
Interventions: Ketamine, Naltrexone Pill, Placebo pill; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pharmacokinetics
Interventions: Colchicine, Ritonavir; Drug
Lead sponsor: Mutual Pharmaceutical Company, Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: East Grand Forks, Minnesota

Conditions: HIV Infections, Syphilis Infection
Interventions: Chembio HIV/Syphilis rapid Point of Care (POC) test, Laboratory-based HIV and syphilis testing; Diagnostic Test
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 14 Years to 45 Years · Female only
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Prostate Cancer
Interventions: Abiraterone acetate; Drug
Lead sponsor: Cougar Biotechnology, Inc.; Industry
Eligibility: 40 Years to 80 Years · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Obesity, Overweight, Type 2 Diabetes
Interventions: LY3549492, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 38
States / cities: Phoenix, Arizona • Scottsdale, Arizona • Greenbrae, California + 33 more

Conditions: Electrical Status Epilepticus of Slow-Wave Sleep
Interventions: Epidiolex 100 mg/mL Oral Solution, Placebo; Drug · Other
Lead sponsor: Northwell Health; Other
Eligibility: 2 Years to 17 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Congenital Heart Diseases, Cardiac Diseases
Interventions: Not listed
Lead sponsor: Matthias Stuber; Other
Eligibility: Not listed
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 9
States / cities: Los Angeles, California • Atlanta, Georgia • Chicago, Illinois + 6 more

Conditions: Depressive Disorder, Major
Interventions: Esketamine, Placebo, Standard of Care; Drug · Other
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 64 Years
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 18
States / cities: San Diego, California • Farmington, Connecticut • Miami, Florida + 14 more

Conditions: Aging Hands
Interventions: Transcutaneous electrical nerve stimulation (TENS), Familiarization; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: 54 Years to 89 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Covid19
Interventions: Quidel quickvue antigen test for COVID-19; Diagnostic Test
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Oxidative Stress, Dyslipidemias
Interventions: Octacosanol, Placebo; Dietary Supplement
Lead sponsor: Kosin University; Other
Eligibility: 17 Years to 19 Years · Male only
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Blindness
Interventions: Magstim Rapid Magnetic Stimulator; Device
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Asthma
Interventions: Lifestyle Factors, Customized use of Dietary Supplements, Currently Accepted Asthma Care Guidelines; Behavioral · Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 19 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast

A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

FGF21 and Fructose Challenge in Humans

Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICU

TelePrEP for At-risk Youth in Colorado

Novel Methods for Implementing Measurement-Based Care for Youth in Low-resource Environments

Identification to Elimination in HCV-Infected Individuals

Bioequivalence Study of Colchicine Tablets

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Drug-Drug Interaction Between Colchicine and Ritonavir

Implementation of an Opt-Out Testing and Rapid Diagnostic Strategy for Syphilis and HIV in Pregnant Patients Presenting to the Emergency Department

A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).

An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide

Neural Substrates Underlying Adaptations in Manual Dexterity of Older Adults

The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners

Effects of Octacosanol During Taekwondo Training

Brain Plasticity of Verbal Memory in the Blind

Functional Medicine in Asthma (FAst) Study